The role of PBRM1 as tumor suppressor is also supported by the fact that ≈80% of the somatic mutations found in the gene result in loss of function (LOF) of the protein, not only in ccRCC but also in other tumor types, including breast and pancreatic cancers. The gene discussed is PBRM1; the disease is neoplasm.